JP2021532098A5 - - Google Patents

Info

Publication number
JP2021532098A5
JP2021532098A5 JP2021502918A JP2021502918A JP2021532098A5 JP 2021532098 A5 JP2021532098 A5 JP 2021532098A5 JP 2021502918 A JP2021502918 A JP 2021502918A JP 2021502918 A JP2021502918 A JP 2021502918A JP 2021532098 A5 JP2021532098 A5 JP 2021532098A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
levodopa
mass
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021502918A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021532098A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/042689 external-priority patent/WO2020018959A1/en
Publication of JP2021532098A publication Critical patent/JP2021532098A/ja
Publication of JP2021532098A5 publication Critical patent/JP2021532098A5/ja
Pending legal-status Critical Current

Links

JP2021502918A 2018-07-19 2019-07-19 パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達 Pending JP2021532098A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862700584P 2018-07-19 2018-07-19
US62/700,584 2018-07-19
US201962820244P 2019-03-18 2019-03-18
US62/820,244 2019-03-18
PCT/US2019/042689 WO2020018959A1 (en) 2018-07-19 2019-07-19 Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease

Publications (2)

Publication Number Publication Date
JP2021532098A JP2021532098A (ja) 2021-11-25
JP2021532098A5 true JP2021532098A5 (enExample) 2022-07-21

Family

ID=69164787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021502918A Pending JP2021532098A (ja) 2018-07-19 2019-07-19 パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達

Country Status (6)

Country Link
US (3) US11517548B2 (enExample)
EP (1) EP3823607A4 (enExample)
JP (1) JP2021532098A (enExample)
KR (1) KR20210034047A (enExample)
CN (1) CN112955134A (enExample)
WO (1) WO2020018959A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117503703B (zh) * 2023-11-09 2024-11-22 广州新济药业科技有限公司 一种左旋多巴鼻喷雾剂及其制备方法及应用

Family Cites Families (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB806284A (en) 1955-11-14 1958-12-23 Chi Ah Lai A new or improved nasal inhaler
US2933259A (en) 1958-03-03 1960-04-19 Jean F Raskin Nozzle head
US3425414A (en) 1965-05-28 1969-02-04 William J La Roche Inhalant dispenser
US3888253A (en) 1972-08-04 1975-06-10 Beecham Group Ltd Device for administration of medicines
FR2224175B1 (enExample) 1973-04-04 1978-04-14 Isf Spa
US3971377A (en) 1974-06-10 1976-07-27 Alza Corporation Medicament dispensing process for inhalation therapy
US3908654A (en) 1974-08-02 1975-09-30 Rit Rech Ind Therapeut Dispensing package for a dry biological and a liquid diluent
ZA758010B (en) 1975-11-14 1977-08-31 Syntex Inc Nasal spray adapter
US4095596A (en) 1976-11-26 1978-06-20 Smithkline Corporation Nasal inhaler
US4227522A (en) 1978-09-05 1980-10-14 Syntex Puerto Rico, Inc. Inhalation device
US4187985A (en) 1978-12-08 1980-02-12 The Continental Group, Inc. Aerosol valve for barrier type packages
BR8007911A (pt) 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
US4412573A (en) 1981-12-28 1983-11-01 Baxter Travenol Laboratories, Inc. Injection site
EP0162854A1 (en) 1983-11-28 1985-12-04 Vortran Corporation Gas-powered nebulizer
AU3439884A (en) 1983-11-28 1985-06-13 Vortran Corp. Single inlet prepackaged inhaler
WO1986001731A1 (en) 1984-09-18 1986-03-27 Vortran Corporation All purpose nebulizer
US4896832A (en) 1987-09-07 1990-01-30 Bespak Plc Dispensing apparatus for metered quantities of pressurised fluid
EP0315964B1 (en) * 1987-11-11 1993-01-07 Laboratoires Pharmascience A novel pharmaceutical composition comprising exifone and water-soluble polymer
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
NZ250988A (en) 1990-06-14 1995-09-26 Rhone Poulenc Rorer Ltd Powder inhaler: swirling chamber with anti-static walls
DE4038049C2 (de) 1990-11-29 1994-12-01 Anschuetz & Co Gmbh Implantierbare Infusionspumpe
US5331954A (en) 1990-12-21 1994-07-26 Novo Nordisk A/S Device for nasal delivery of liquid medications
IT1249600B (it) 1991-02-21 1995-03-09 Elettro Plastica Spa Erogatore nasale di sostanze farmaceutiche nebulizzate
US6681767B1 (en) 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
IT1250691B (it) 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
GB9125699D0 (en) 1991-12-03 1992-01-29 Glaxo Group Ltd Device
GB9311892D0 (en) 1993-06-09 1993-07-28 Glaxo Wellcome Australia Ltd Device
US5349947A (en) 1993-07-15 1994-09-27 Newhouse Michael T Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
US5516006A (en) 1993-07-30 1996-05-14 Meshberg; Philip Nasal dispenser
US5398850A (en) 1993-08-06 1995-03-21 River Medical, Inc. Gas delivery apparatus for infusion
IT1266794B1 (it) 1993-11-09 1997-01-21 Faustino Ballini Dispositivo a doccia micronizzata per il lavaggio delle cavita' nasali e limitrofe
AU700162B2 (en) 1994-05-13 1998-12-24 Aradigm Corporation Narcotic containing aerosol formulation
US5435282A (en) 1994-05-19 1995-07-25 Habley Medical Technology Corporation Nebulizer
JP3372105B2 (ja) 1994-05-26 2003-01-27 株式会社日立ユニシアオートモティブ 吸入式投薬器
US5901703A (en) 1995-02-06 1999-05-11 Unisia Jecs Corporation Medicine administering device for nasal cavities
DE19518580A1 (de) 1995-05-20 1996-11-21 Thomas Ossinger Lötbadtiegel
JPH08322934A (ja) 1995-05-29 1996-12-10 Unisia Jecs Corp 鼻腔用投薬器
DE19523516C1 (de) 1995-06-30 1996-10-31 Asta Medica Ag Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
US5823183A (en) 1995-08-02 1998-10-20 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
GB9516984D0 (en) 1995-08-18 1995-10-18 Pharmasol Ltd Spray applicator
IE77523B1 (en) 1995-09-11 1997-12-17 Elan Med Tech Medicament delivery device
US5711488A (en) 1995-10-13 1998-01-27 The Procter & Gamble Company High pressure swirl atomizer
US6678553B2 (en) 1995-11-21 2004-01-13 Intraabrain International Nv Device for enhanced delivery of biologically active substances and compounds in an organism
US5797390A (en) 1996-03-06 1998-08-25 Mcsoley; Thomas E. Nasal inhaler having a directed spray pattern
AUPN976496A0 (en) 1996-05-10 1996-05-30 Glaxo Wellcome Australia Ltd Unit dose dispensing device
US6595202B2 (en) 1996-05-13 2003-07-22 Universidad De Sevilla Device and method for creating aerosols for drug delivery
DE19622124A1 (de) 1996-06-01 1997-12-04 Alfred Von Schuckmann Gerät zum Aufbringen von Flüssigkeiten
US6158676A (en) 1996-06-21 2000-12-12 Hughes Technology Group, L.L.C. Micro-atomizing device
US5906198A (en) 1996-07-16 1999-05-25 Flickinger; William J. Nasal nebulizer
US6410046B1 (en) 1996-11-19 2002-06-25 Intrabrain International Nv Administering pharmaceuticals to the mammalian central nervous system
US7033598B2 (en) 1996-11-19 2006-04-25 Intrabrain International N.V. Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
DE19704849B4 (de) 1997-02-08 2011-02-17 Ing. Erich Pfeiffer Gmbh Austragvorrichtung für Medien
IS4516A (is) 1997-07-01 1999-01-02 Gizurarson Sveinbjörn Nýtt lyfjaform
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
GB9719775D0 (en) 1997-09-18 1997-11-19 Glaxo Group Ltd Device
US5954696A (en) 1997-12-15 1999-09-21 B. Braun Medical, Inc. Pressure infusion pump
US7335186B2 (en) 1998-03-13 2008-02-26 Alexander George Brian O'Neil Patient controlled drug delivery device
US6113078A (en) 1998-03-18 2000-09-05 Lytesyde, Llc Fluid processing method
US6062213A (en) 1998-06-16 2000-05-16 Fuisz Technologies Ltd. Single unit dose inhalation therapy device
ES2234266T3 (es) 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
FR2782024B1 (fr) 1998-08-04 2000-10-13 Valois Sa Tete de distribution et dispositif de distribution de produit fluide comportant une telle tete
GB2345010B (en) 1998-12-17 2002-12-31 Electrosols Ltd A delivery device
US6294153B1 (en) 1998-12-21 2001-09-25 Generex Pharmaceuticals, Inc. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
WO2000044432A1 (en) 1999-01-27 2000-08-03 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB0114272D0 (en) 2001-06-12 2001-08-01 Optinose As Nasal delivery device
CN1736502A (zh) 1999-03-03 2006-02-22 奥普蒂诺斯公司 鼻传送装置
GB0121568D0 (en) 2001-09-06 2001-10-24 Optinose As Nasal delivery device
AU3751700A (en) 1999-03-17 2000-10-04 Emsar, Inc. Apparatus and method for dispensing a medicinal spray
WO2000057851A2 (en) 1999-03-26 2000-10-05 Pozen Inc. High potency dihydroergotamine compositions
DE19944209A1 (de) 1999-09-15 2001-03-22 Pfeiffer Erich Gmbh & Co Kg Spender zum ggf. zerstäubten Ausbringen eines insbesondere flüssigen Mediums aus einem Behältnis
US6382204B1 (en) 1999-10-14 2002-05-07 Becton Dickinson And Company Drug delivery system including holder and drug container
EP1092447B1 (en) 1999-10-14 2004-01-07 Becton Dickinson and Company Nasal delivery device including spray nozzle
US6367471B1 (en) 1999-11-01 2002-04-09 Sheffield Pharmaceuticals, Inc. Internal vortex mechanism for inhaler device
US6810872B1 (en) 1999-12-10 2004-11-02 Unisia Jecs Corporation Inhalant medicator
US6302101B1 (en) 1999-12-14 2001-10-16 Daniel Py System and method for application of medicament into the nasal passage
CN1402629A (zh) * 1999-12-23 2003-03-12 辉瑞产品公司 提供提高的药物浓度的药物组合物
US6734162B2 (en) 2000-01-24 2004-05-11 Minimed Inc. Mixed buffer system for stabilizing polypeptide formulations
US6585957B1 (en) 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6540983B1 (en) 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
US6644305B2 (en) 2000-04-14 2003-11-11 Trudell Medical International Nasal inhaler
GB0015309D0 (en) 2000-06-21 2000-08-16 Djupesland Per G Apparatus
IT1317998B1 (it) 2000-06-26 2003-07-21 Medical Internat Licensing N V Valvola erogatrice per spray nasale.
IT1318646B1 (it) 2000-07-26 2003-08-27 Medical Internat Licensing N V Ugello pr somministrazioni e lavaggi nasali.
EA006384B1 (ru) 2000-07-31 2005-12-29 Нюкомед Данмарк А/С Композиция фентанила для интраназального введения
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
CA2359813C (en) 2000-10-24 2008-04-22 Richard L. Jones Nicotine mucosal spray
US6644309B2 (en) 2001-01-12 2003-11-11 Becton, Dickinson And Company Medicament respiratory delivery device and method
ZA200306564B (en) 2001-02-26 2004-10-15 Optinose As Nasal devices.
GB0109002D0 (en) 2001-04-10 2001-05-30 Glaxo Group Ltd Dispenser
GB0109001D0 (en) 2001-04-10 2001-05-30 Glaxo Group Ltd Dispenser
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
EP1279404A1 (en) 2001-07-26 2003-01-29 Istituto Superiore di Sanità Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases
WO2003026559A2 (en) 2001-09-28 2003-04-03 Kurve Technology, Inc Nasal nebulizer
GB2380410B (en) 2001-10-05 2003-11-19 Alchemy Healthcare Ltd Apparatus for the nasal or oral delivery of a medicament
US7021561B2 (en) 2001-12-18 2006-04-04 Becton, Dickinson And Company Spray device and method
GB0204829D0 (en) 2002-03-01 2002-04-17 Glaxo Group Ltd A fluid dispensing device
US7666876B2 (en) 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
AU2003218307B8 (en) * 2002-03-20 2006-08-31 Alkermes, Inc. Pulmonary delivery for levodopa
GB0207422D0 (en) 2002-03-28 2002-05-08 Optinose As Nasal devices
GB0209494D0 (en) 2002-04-25 2002-06-05 Optinose As Nasal devices
WO2003093299A2 (en) 2002-05-06 2003-11-13 Thomas Jefferson University Insulin-associated peptides with effects on cerebral health
AU2003249623A1 (en) 2002-05-09 2003-12-12 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
US7220457B2 (en) 2002-06-06 2007-05-22 Anderson Steven R Air atomizing assembly and method and system of applying an air atomized material
GB0215270D0 (en) 2002-07-02 2002-08-14 Optinose As Nasal devices
GB0215904D0 (en) 2002-07-09 2002-08-21 Team Holdings Uk Ltd Drug delivery system and method
GB0217198D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
GB0309354D0 (en) 2003-04-24 2003-06-04 Glaxo Group Ltd Nozzle for a nasal inhaler
DE10321902A1 (de) 2003-05-06 2004-12-09 Ing. Erich Pfeiffer Gmbh Austragvorrichtung für zumindest ein Medium
GB0319119D0 (en) 2003-08-14 2003-09-17 Optinose As Delivery devices
GB0320171D0 (en) 2003-08-28 2003-10-01 Optinose As Delivery devices
DE602004031134D1 (de) 2003-08-29 2011-03-03 Transform Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
EP1673123A2 (en) 2003-09-05 2006-06-28 Kurve Technology, Inc. Integrated nebulizer and particle dispersing chamber for delivery of medicament
US20070172517A1 (en) 2003-09-17 2007-07-26 Ben-Sasson Shmuel A Compositions capable of facilitation penetration across a biological barrier
GB0322284D0 (en) 2003-09-23 2003-10-22 Glaxo Group Ltd Medicament dispenser
US8134010B2 (en) * 2004-05-05 2012-03-13 Renopharm Ltd. Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
US7832394B2 (en) 2004-12-22 2010-11-16 Schechter Alan M Apparatus for dispensing pressurized contents
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
MX2007012157A (es) 2005-04-01 2008-03-14 Intezyne Technologies Llc Micelas polimericas para suministro de farmacos.
GB0515592D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Nozzle for a nasal inhaler
WO2007017249A1 (en) * 2005-08-08 2007-02-15 Abbott Gmbh & Co. Kg Dosage forms with improved bioavailability
US20070074722A1 (en) 2005-09-21 2007-04-05 Kurve Technology, Inc. Medicament delivery control, monitoring, and reporting system and method
US20080248099A1 (en) 2005-11-11 2008-10-09 Ishii Douglas N Method for Treating Disease or Disorder of Adult Central Nervous System Associated with Tissue Shrinkage or Atrophy by Administration of Insulin
EP1960022A1 (en) 2005-11-29 2008-08-27 Alza Corporation Nasal delivery device for the delivery of a substance to the olfactory region
US20070202051A1 (en) 2006-02-10 2007-08-30 Pari Gmbh Aerosols for sinunasal drug delivery
US8171929B2 (en) 2006-02-14 2012-05-08 Optinose As Delivery device and method
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB0605799D0 (en) 2006-03-23 2006-05-03 Optinose As Nasal delivery devices
US7841338B2 (en) 2006-04-13 2010-11-30 Boehringer Ingelheim International Gmbh Dispensing device
US7425542B2 (en) * 2006-06-23 2008-09-16 Aegis Therapeutics, Inc. Stabilizing alkylglycoside compositions and methods thereof
GB2440316A (en) 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
EP2106268B1 (en) 2006-08-30 2018-12-12 Kurve Technology, Inc. Aerosol generating and delivery device
FR2908753B1 (fr) 2006-11-16 2011-11-11 Becton Dickinson France Dispositif pour delivrer automatiquement des doses successives de produit
WO2008067254A2 (en) 2006-11-27 2008-06-05 Abbott Respiratory Llc Nasal drug delivery device and method
GB0623732D0 (en) 2006-11-28 2007-01-10 Optinose As Powder delivery devices
GB0623728D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery devices
WO2008097664A1 (en) 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
US8530463B2 (en) 2007-05-07 2013-09-10 Hale Biopharma Ventures Llc Multimodal particulate formulations
EP2152240A4 (en) 2007-06-08 2012-05-09 Healthpartners Res Foundation PHARMACEUTICAL COMPOSITIONS AND METHOD FOR REINFORCED TARGETING OF THERAPEUTIC COMPOUNDS TO THE CENTRAL NERVOUS SYSTEM
GB0719299D0 (en) 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
WO2009049215A1 (en) 2007-10-10 2009-04-16 Wake Forest University Health Sciences Methods to reduce the effects of sleep deprivation
CN101910113A (zh) * 2007-12-28 2010-12-08 怡百克制药公司 左旋多巴控释制剂及其用途
US8757146B2 (en) 2008-02-07 2014-06-24 University Of Washington Through Its Center For Commercialization Circumferential aerosol device
WO2009102976A2 (en) 2008-02-15 2009-08-20 Timothy Sean Immel Aerosol therapy device with high frequency delivery
US8517026B2 (en) 2008-02-25 2013-08-27 Adva Beck Amon Nasal inserts
NO329804B1 (no) 2009-02-09 2010-12-20 Fmc Kongsberg Subsea As Kobling for bruk i et stigeror, stigeror med en slik kobling og fremgangsmate for a oke operasjonsvinduet til et stigeror
KR101220182B1 (ko) * 2009-02-25 2013-01-11 에스케이바이오팜 주식회사 치환된 아졸 유도체 화합물, 이를 포함하는 약제학적 조성물 및 이를 이용한 파킨슨씨 병 치료방법
WO2010131486A1 (en) 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US8839790B2 (en) 2009-07-29 2014-09-23 Adva Beck Arnon Nasal inserts
US8408427B2 (en) 2009-09-07 2013-04-02 Mk International Pty Ltd Single dose nasal spray pump
WO2011047412A1 (en) 2009-10-22 2011-04-28 The Heart Research Institute Ltd Tyrosine and l-dopa for reducing l-dopa incorporation into proteins
US8925544B2 (en) 2009-12-08 2015-01-06 Medinvent, Llc Portable nebulizer device
WO2011143721A1 (en) * 2010-05-21 2011-11-24 Gosforth Centre (Holdings) Pty Ltd Compositions and methods for treating neurodegenerative disorders
TW201304822A (zh) 2010-11-15 2013-02-01 Vectura Ltd 組成物及用途
CA2820554A1 (en) 2010-11-29 2012-06-07 Sanofi-Aventis Deutschland Gmbh Medicated module for an inhaler
JP6339371B2 (ja) 2011-03-03 2018-06-06 インペル ニューロファーマ インコーポレイテッド 経鼻薬物送達デバイス
CN103619485B (zh) 2011-05-09 2017-08-08 英倍尔药业股份有限公司 用于鼻腔药物递送的喷嘴
US8987199B2 (en) 2011-06-15 2015-03-24 Nerve Access, Inc. Pharmaceutical compositions for intranasal administration for the treatment of neurodegenerative disorders
DE102012201178B3 (de) 2012-01-27 2013-02-14 Aptar Radolfzell Gmbh Düseneinheit und Spender mit einer solchen
JP2015523989A (ja) * 2012-06-11 2015-08-20 サイコジェニックス・インコーポレーテッドPsychogenics Inc. パーキンソン病の処置に伴う運動不全及び運動障害副作用の処置
JP2015526481A (ja) 2012-08-24 2015-09-10 ブイアール1 インコーポレイテッド 片頭痛の治療用組成物
KR20210075224A (ko) 2012-10-22 2021-06-22 키비타스 테라퓨틱스, 인코포레이티드. 파킨슨병의 빠른 경감을 위한 레보도파 제형
DE102013100473A1 (de) 2013-01-17 2014-07-17 Seho Systemtechnik Gmbh Verfahren und Vorrichtung zum Reinigen einer Lötdüse
EP2991713B1 (en) 2013-04-28 2019-06-19 Impel Neuropharma Inc. Medical unit dose container
DK3049059T3 (da) 2013-09-24 2022-01-31 Satsuma Pharmaceuticals Inc Intranasal dhe formulering til behandlingen af hovedpine
US20160296591A1 (en) * 2013-10-11 2016-10-13 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of bdnf-related conditions
RU2545734C1 (ru) 2014-01-31 2015-04-10 Открытое акционерное общество "Всероссийский Научный Центр Молекулярной Диагностики и Лечения" (ОАО "ВНЦМДЛ) Лекарственный препарат для лечения болезни паркинсона
US9603905B2 (en) 2014-03-13 2017-03-28 The Research Foundation For Mental Hygiene, Inc Intranasal insulin administration for the minimization of anesthesia-induced memory loss
EP3134077A4 (en) 2014-04-21 2017-12-20 Civitas Therapeutics, Inc. Rapid relief of motor fluctuations in parkinson's disease
US20150335712A1 (en) * 2014-05-21 2015-11-26 Stemnion, Inc. Treatment of Diseases and Conditions Caused by Increased Vascular Permeability
US20180200186A1 (en) * 2015-07-09 2018-07-19 Insmed Incorporated Compositions and methods for treating lung diseases and lung injury
US10555922B2 (en) * 2015-09-04 2020-02-11 Lobsor Pharmaceuticals Aktiebolag Method of treating a dopamine related disorder in a subject by administering levodopa, in combination with a dopamine decarboxylase inhibitor and a catechol-o-methyltransferase inhibitor
JP7049683B2 (ja) 2016-04-04 2022-04-07 シノピア バイオサイエンシーズ,インク. トラピジルを使用する錐体外路症候群の処置

Similar Documents

Publication Publication Date Title
AU2025204271A1 (en) Microcrystalline diketopiperazine compositions and methods
US20220296559A1 (en) Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
FI4279070T3 (fi) Koostumus sisältäen 5-metoksi-N,N-dimetyylitryotamini-bentsoaattisuolaa
JP2018199688A5 (enExample)
JP2018162258A (ja) 超低密度肺粉剤
RU2019100425A (ru) Новая доза и препаративная форма
JP2008536546A5 (enExample)
JP2013224331A5 (enExample)
US20120070417A1 (en) Anti-influenza formulations and methods
CN116075306B (zh) 用于治疗冠状病毒感染的化合物
RU2013142268A (ru) Фармацевтическая композиция
RU2019121646A (ru) Способы и композиции для лечения легочной гипертензии и других заболеваний легких
JP2016040316A5 (enExample)
CN1379667A (zh) 预防和治疗感冒和流感样症状的组合物和它们的使用方法
JP2011520911A5 (enExample)
KR20140069091A (ko) 기침 및 기침으로 인한 발작 치료
WO2015014209A1 (zh) 稳定渗透压的丙酮酸药物组成及其在健康人和肺病病人中的排毒作用
CN1972730A (zh) 格隆溴铵用于治疗儿童哮喘
JP2025038163A (ja) 肺線維症を処置するための方法及び組成物
JP2021532098A5 (enExample)
WO2023150747A1 (en) Dry powder compositions of bedaquiline and salts and methods of use thereof
ES2309357T3 (es) Nueva combinacion sinergica que comprende roflumilast y formoterol.
MX2013004030A (es) Composicion farmaceutica a base de denufosol para tratar fibrosis quistica.
JP2012530121A (ja) 咳の治療のためのテオブロミン
JP2023540259A (ja) 肺感染症の治療および予防用のグルコシダーゼ阻害剤